SCHEMBL1897348

SCHEMBL1897348

C=C(CCCCCCCCCC(C=O)CCC=CCCCCC)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 1/20 0.49
FNTB P49356 1/20 0.49
PPARG P37231 5/20 0.49
PPARD Q03181 5/20 0.49
PPARA Q07869 5/20 0.49
F7 P08709 5/20 0.49
F3 P13726 5/20 0.49
TERT O14746 3/20 0.49
PTPN1 P18031 3/20 0.49
HSD17B10 Q99714 3/20 0.49
FABP4 P15090 3/20 0.49
MAPT P10636 2/20 0.49
BLM P54132 2/20 0.49
LMNA P02545 2/20 0.49
ALOX15 P16050 2/20 0.49
DUSP3 P51452 2/20 0.49
CYP19A1 P11511 2/20 0.49
PTGS1 P23219 2/20 0.49
NR4A2 P43354 2/20 0.49
SIRT6 Q8N6T7 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1896642 0.90 FFAR4 (0.45) FNTAFNTBPPARGPPARDPPARA
SCHEMBL1900176 0.90 FFAR4 (0.45) FNTAFNTBPPARGPPARDPPARA
SCHEMBL1897351 0.90 FFAR4 (0.45) FNTAFNTBPPARGPPARDPPARA
SCHEMBL1905242 0.90 FFAR4 (0.45) FNTAFNTBPPARGPPARDPPARA
SCHEMBL1897509 0.89 FFAR4 (0.44) FNTAFNTBPPARGPPARDPPARA
SCHEMBL1903045 0.88 ALDH1A1 (0.51) PPARGPPARDPPARAF7F3
SCHEMBL17062989 0.86 PPARG (0.68) PPARGPPARDPPARAF7F3
SCHEMBL17062987 0.86 PPARG (0.68) PPARGPPARDPPARAF7F3
SCHEMBL23749583 0.84 PPARG (0.67) FNTAFNTBPPARGPPARDPPARA
SCHEMBL11546605 0.84 PPARG (0.67) FNTAFNTBPPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321254-B1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK ROEHM GMBH (DE) 2014-07-30 EP disclosed
EP-2324069-B1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING EVONIK ROEHM GMBH (DE) 2013-12-18 EP disclosed
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK ROEHM GMBH (DE) 2011-06-16 US disclosed
EP-2324069-A1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING Evonik Röhm GmbH (DE) 2011-05-25 EP disclosed
WO-2010026118-A1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING EVONIK RÖHM GMBH (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD DNMT1, TET1, MGMT FNTA 4411/4885FNTB 3915/4885PPARG 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.